Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Analytikerkommentar

Scanfil Q3'25 flash comment: The earnings trend turned as expected

Af Antti ViljakainenHead of Research
Scanfil

Oversigt

  • Scanfil's Q3 revenue increased by 10% to 191 MEUR, supported by the SRX acquisition and organic growth, though slightly below expectations due to currency impacts.
  • Adjusted EBITA rose by 10% to 14.1 MEUR, with profitability at 7.4%, aligning with estimates but missing expectations due to revenue shortfalls and negative currency effects.
  • Reported Q3 EPS increased to EUR 0.14, with operational earnings growth not fully reflected in the bottom line due to non-recurring costs and higher tax rates.
  • Scanfil maintained its 2025 guidance of 780-920 MEUR revenue and 55-68 MEUR adjusted EBIT, with a positive Q4 outlook and significant new project wins, though conversion to revenue is slow.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Estimates Q3'24Q3'25Q3'25eQ3'25eConsensusDifference (%)2025e
MEUR / EUR ComparisonActualizedInderesConsensusLow High Act. vs. Inderes Inderes
Revenue 173191197    -3%835
EBITA (adj.) 12.814.114.6    -3%60.9
EBIT 12.412.613.5    -7%56.8
PTP 12.212.013.1    -8%54.7
EPS (reported) 0.130.140.16    -13%0.65
           
Revenue growth-% -18.6 %10.4 %13.7 %    -3.3 pp7.1 %
EBITA-% (adj.) 7.4 %7.4 %7.4 %    0 pp7.3 %

Source: Inderes

Translation: Original published in Finnish on 10/24/2025 at 8:52 am EET.

Scanfil released its Q3 report this morning. The company's revenue and operational result turned upwards in Q3, in line with our expectations, although the actual figures were slightly below our forecasts. However, the situation was neutralized by strong growth in newly won projects. Scanfil reiterated its guidance, which was expected.  

Revenue turned to organic growth in Q3

In Q3, Scanfil's revenue increased by 10% to 191 MEUR from a modest comparison level. The SRX acquisition supported growth by 8.4 MEUR, or about 5 percentage points, and currencies created a headwind of just under 3 percentage points for the topline. Thus, currency-adjusted organic growth rose to a good 8% level after a long negative period. However, Q3 revenue was slightly below our expectations, especially due to currencies. Of the regions, all but Central Europe, which contracted slightly, grew significantly. However, the forecast beat came from Northern Europe, where a single customer in the Cleantech&Energy segment was apparently boosting revenue.

Profitability also improved with growth but without operating leverage

Scanfil's adjusted EBITA rose with revenue by 10% to 14.1 MEUR. Profitability (adj. EBITA-%) settled at 7.4%, in line with the comparison period and our estimate, but the earnings also slightly missed our expectations, driven by revenue. Exchange rates also had a clearly negative impact of 0.9 MEUR on the Q3 result. Of the regions, Northern Europe clearly exceeded our forecast due to the high revenue level and probably also the high margins of the mentioned project, while in other regions the earnings fell short of our expectations.

On the bottom line, Scanfil recorded small non-recurring costs in Q3 related to the ADCO and MB acquisitions, in addition to the usual PPA depreciations. Financing expenses were roughly at the company's normal level, but the tax rate rose slightly higher than our expectations. Thus, Scanfil's reported Q3 EPS only increased by one cent year-on-year to EUR 0.14 per share, meaning that operational earnings growth did not carry through to the bottom line with the usual strength. In terms of cash flow, the report was weaker, as cash flow from operating activities remained subdued relative to the result and clearly weaker than the exceptionally strong comparison period. The reasons for this are likely due to working capital being tied up by volume growth.

Guidance remained unchanged as expected

Scanfil reiterated its guidance of 2025 of 780-920 MEUR revenue and 55-68 MEUR adjusted EBIT. The reiterated guidance was in line with our expectations. Based on the comments, the outlook for Q4 is positive. In our view, the company will exceed the lower end of the guidance range even with the current structure (whereas the upper end is very optimistic), and the ADCO and MB acquisitions expected to close in Q4 should provide a slight additional boost.  The company succeeded in winning new projects worth as much as 72 MEUR in Q3, which corresponds to a sharp year-on-year growth of around 30% year. However, the conversion of won new projects into revenue has proven slow, so we do not believe the wins will lead to an abrupt acceleration of growth, but rather to a slower upward trend. Also, the big picture of the company's market situation seems to be similar according to our preliminary estimates.

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Læs mere på virksomhedsside

Key Estimate Figures17.07

202425e26e
Omsætning779,9844,01.005,7
vækst-%-13,5 %8,2 %19,2 %
EBIT (adj.)54,960,975,7
EBIT-% (adj.)7,0 %7,2 %7,5 %
EPS (adj.)0,620,700,85
Udbytte0,240,260,28
Udbytte %2,9 %2,7 %2,9 %
P/E (adj.)13,314,111,6
EV/EBITDA7,69,17,1

Forumopdateringer

Kommentaren er her. Afslutningen af MB-handlen trækker lidt ud, hvilket opklaringen af den uventede komplikation forårsaget af branden sandsynligvis...
20.11.2025, 08.37
af Antti Viljakainen
5
Lad os lægge denne friske Scanfil-meddelelse her. 19.11.2025 12:15:11 EET | Scanfil Oyj | Insiderviden Scanfil Oyj Børsmeddelelse 19.11.2025...
19.11.2025, 23.02
af Sijoittaja-alokas
3
Isa og Antti diskuterede Scanfil. Det overordnede billede af Scanfils Q3-rapport var ret neutralt. Udsigterne er positive på både kort og lang...
18.11.2025, 23.22
af Sijoittaja-alokas
1
Inderes Scanfil: Revenue growth could be close to 20% y/y in 2026 - Nordea - Inderes Organic growth returned in Q3 y/y after some challenging...
27.10.2025, 09.19
af Dissidentti
4
Antti har lavet en ny virksomhedsrapport efter Q3. *Scanfils Q3-rapport, der blev offentliggjort fredag, var efter vores mening ret neutral,...
27.10.2025, 07.12
af Sijoittaja-alokas
3
Vækst i Amerika Omsætningen voksede især i Amerika på trods af valutakurseffekter. ”Justeret for effekten af valutakursændringer voksede oms...
24.10.2025, 06.00
af Dissidentti
7
Scanfil Q3 2025: Tilbage til organisk vækst! Omsætningen voksede 10,4 % til 191,3 mio. euro, og EBITA voksede til 14,1 mio. euro Den organiske...
24.10.2025, 05.11
af Pasi Hiedanpää
23
Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.